Connor, Clark & Lunn Investment Management (CC&L)’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.17M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $954K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $6.71M | Sell |
|
|||||
|
2021
Q4 | $10.8M | Sell |
|
|||||
|
2021
Q3 | $9.51M | Buy |
|
|||||
|
2021
Q2 | $7.38M | Buy |
|
|||||
|
2021
Q1 | $6.15M | Buy |
|
|||||
|
2020
Q4 | $5.05M | Buy |
|
|||||
|
2020
Q3 | $1.47M | Buy |
|